HOME >> MEDICINE >> NEWS
Relatives of women with faulty gene have high risk of breast cancer

Relatives of women who carry a damaged version of the CHEK2 gene and have cancer in both breasts have a substantially higher lifetime risk of breast cancer than those related to non-carriers, according to a study in this week's issue of The Lancet.

Women who have a faulty version of the CHEK2 gene called CHEK2*1100delC have double the chance of developing breast cancer when compared with non-carriers. But the gene variant could confer a greater risk in women with a family history of the disease, particularly those with a family history of bilateral breast cancer (cancer affecting both breasts).

Julian Peto (The London School of Hygiene and Tropical Medicine, UK) and colleagues tested 469 patients with bilateral breast cancer for the CHEK2*1100delC variant. They then analysed the risk of breast cancer, prostate cancer, and all other cancers in first-degree relatives of carriers and non-carriers. The investigators found that first-degree relatives of women who have bilateral breast cancer and a normal version of CHEK2 had a cumulative breast cancer risk of 23.8% by age 80 years compared with an expected cumulative risk of 7.9%. However, for relatives of women with bilateral breast cancer and the CHEK2*1100delC mutation the cumulative risk by age 80 was 58.8%.

Study author Olivia Fletcher (The London School of Hygiene and Tropical Medicine, UK) states: "Roughly 2000 bilateral breast cancer cases are diagnosed in the UK every year, of whom 2% are carriers of CHEK2*110delC. Testing for CHEK2*1100delC in women with a family history of breast cancer, especially those with a bilaterally affected first-degree relative, could be clinically useful for predicting personal risks."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
27-Oct-2005


Page: 1

Related medicine news :

1. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
2. Some women benefit more from exercise when emphasis is on health, not appearance
3. Even older women at high risk have little interest in being tested for HIV, study finds
4. In women, caffeine may protect memory
5. Why women get more migraines than men
6. Hot flashes may be welcome sign in women with breast cancer, study says
7. Study finds difference in survival rates among white and black women with advanced breast cancer
8. Tumor cell activity may provide clues for treating breast cancer in young women
9. Men worry more about penile size than women, says 60-year-old research review
10. Focused ultrasound relieves fibroid symptoms in women
11. Increasing radiation dose shortens treatment time for women who choose breast sparing treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2019)... ... March 20, 2019 , ... Confluent ... (BRPT-Lake), a physical therapist owned outpatient physical and occupational therapy practice with seven ... Physical Therapy was founded more than 55 years ago, our mission has been ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... Santa Clara County, announced that the National Committee for Quality Assurance (NCQA) has ... of business. NCQA is a private, not-for-profit organization dedicated to improving health care ...
(Date:3/20/2019)... ... March 20, 2019 , ... Many companies are ... for safe clinical testing. , A recent publication in the Journal of Stem ... Inc. that has shown promising results for the reversal of aging. The paper, ...
(Date:3/20/2019)... Ohio (PRWEB) , ... March 20, 2019 , ... ... or back pain from disc herniation's, degenerative disc disease, spinal stenosis, sciatica ... all in one location! , At Advanced Spine Joint and Wellness provider's ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... its Crominex®3+, a composition of trivalent chromium chloride combined with extracts of amla ... function. This newly granted patent, along with 7 clinical studies on Crominex®3+, establish ...
Breaking Medicine News(10 mins):
(Date:3/20/2019)... ... March 20, 2019 , ... ... which lung cancer patients will respond to chemotherapy, according to a new study ... typically the first-line treatment of advanced-stage non–small cell lung cancer (NSCLC). However, only ...
(Date:3/20/2019)... ... March 20, 2019 , ... SmartLinx, ... Care Centre used its SmartLinx suite to refute a false allegation and immediately ... the Illinois Department of Public Health regulators alleged the facility was out of ...
(Date:3/19/2019)... ... March 19, 2019 , ... TreTap Launches First-Ever CBD Infused ... week online contest – One winner will receive TreTap beverages for a year ... CBD infused maple water beverage. Tretap, which was acquired by Vermont’s original CBD store ...
Breaking Medicine Technology:
Cached News: